12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers

  • Celldex Therapeutics CLDX stock increased by 30.1% to $33.8 during Monday's pre-market session. The company's market cap stands at $1.5 billion. As per the press release, Q3 earnings came out 2 days ago.
  • Sensei Biotherapeutics SNSE shares moved upwards by 21.15% to $0.84. The company's market cap stands at $22.2 million.
  • Baudax Bio BXRX shares rose 14.4% to $0.25. The company's market cap stands at $2.3 million.
  • CervoMed CRVO shares moved upwards by 14.17% to $12.48. The market value of their outstanding shares is at $70.8 million.
  • Repare Therapeutics RPTX stock increased by 13.38% to $4.32. The market value of their outstanding shares is at $181.8 million.
  • OptimizeRx OPRX shares rose 11.3% to $9.45. The market value of their outstanding shares is at $170.8 million. The company's, Q3 earnings came out today.

Losers

  • Cerus CERS shares fell 20.8% to $1.37 during Monday's pre-market session. The market value of their outstanding shares is at $248.2 million. As per the news, the Q3 earnings report came out 2 days ago.
  • MoonLake MLTX shares declined by 18.1% to $42.0. The company's market cap stands at $2.2 billion.
  • NexImmune NEXI shares decreased by 14.68% to $2.5. The company's market cap stands at $2.6 million.
  • Acurx Pharmaceuticals ACXP shares fell 10.67% to $2.93. The company's market cap stands at $38.1 million.
  • Altamira Therapeutics CYTO shares declined by 9.47% to $0.14. The company's market cap stands at $1.0 million.
  • Kazia Therapeutics KZIA shares declined by 9.28% to $0.43. The company's market cap stands at $10.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!